Clinical Trial Update: A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency

View source ↗

Summary

A clinical trial studying participants with moderate to severe major depressive disorder in a psychiatric emergency setting has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Depressive Disorder, Major | Status: WITHDRAWN